Status:
ACTIVE_NOT_RECRUITING
Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia
Lead Sponsor:
Alliance for Clinical Trials in Oncology
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Leukemia
Eligibility:
All Genders
15+ years
Brief Summary
This research trial studies multidrug resistance genes in patients with acute myeloid leukemia. Studying samples of bone marrow or blood from patients with cancer in the laboratory may help doctors le...
Detailed Description
PRIMARY OBJECTIVES: I. To investigate the association of common single nucleotide polymorphisms (SNPs) and haplotypes of the three multidrug resistance (MDR) genes with treatment outcome in the clini...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Diagnosis of acute myeloid leukemia
- Treated on protocols CALGB-9621, CALGB-9720, or CALGB-19808
- Registered on the mandatory companion Leukemia Tissue Bank Protocol CALGB-9665
- Registration on another companion trial, CALGB-9760, (Multidrug Resistance Studies in Acute Leukemia) allowed
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
October 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00898456
Start Date
October 1 2006
Last Update
August 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fort Wayne Medical Oncology and Hematology
Fort Wayne, Indiana, United States, 46845